Insmed

The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs
Yahoo/Benzinga
biotech
IPOs
Pain Therapeutics
Remoxy
Vertex Pharmaceuticals
lumacaftor/ivacaftor
Alnylam
Patisiran
Regeneron
Eylea
Insmed
Paratek
Vaccinex
Flag link:
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?
Motley Fool
biotech
Insmed
NewLink Genetics
Voyager Therapeutics
ALIS
indoximod/Keytruda
VY-AADC01
Flag link:
Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch
Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch
Endpoints
Insmed
clinical trials
Arikayce
ALIS
Flag link:
AstraZeneca licenses respiratory drug to Insmed
AstraZeneca licenses respiratory drug to Insmed
Yahoo/Reuters
AstraZeneca
Insmed
AZD7986
Respiratory
Flag link:
Insmed reports 2Q loss
Insmed reports 2Q loss
Yahoo/AP
Insmed
earnings
Flag link:
As Antibiotics Stop Working, Five Biotechs Seek Cures
As Antibiotics Stop Working, Five Biotechs Seek Cures
24/7 Wall St
antibiotic resistance
antibiotics
Cubist Pharmaceuticals
Durata
Insmed
Medicines Company
Tetraphase Pharmaceuticals
Flag link:
8 Biotech Events To Anticipate This Year: Part One
8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Zohydro
Zogenix
Zybrestat
Oxigene
Arikayce
Insmed
obeticholic acid
Intercept Pharmaceuticals
Flag link:
Insmed's lung infection drug fails mid-stage study
Insmed's lung infection drug fails mid-stage study
Yahoo/Reuters
Insmed
Arikace
nontuberculous mycobacterial lung infections
Flag link:
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Teva Acquisition Machine Gears Up: Who Is the Next Target?
Yahoo/24-7 Wall St
Teva Pharmaceuticals
M&A
Idenix
Insmed
NuPathe
InterMune
Puma Biotechnology
Flag link:
UBS Has Nine Biotech Buyout and Merger Candidates
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
Flag link:
Problems Found With Insmed's Analysis of Arikace Cystic Fibrosis Study
Problems Found With Insmed's Analysis of Arikace Cystic Fibrosis Study
TheStreet.com
Insmed
Arikace
cystic fibrosis
Flag link:
New Patents for Insmed's Arikace
New Patents for Insmed's Arikace
Yahoo/Zacks
patents
Insmed
Arikace
Flag link:
Our BioPharma Catalyst Watch List
Our BioPharma Catalyst Watch List
Seeking Alpha
Astex
Biodel
Insmed
MannKind
Onconova
Afrezza
Dacogen
Arikace
Rigosertib
Flag link:
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
Flag link:
Insmed retreats after Arikace results
Insmed retreats after Arikace results
The Fly on the Wall
Insmed
Arikace
Novartis
Flag link:
Small-Cap Biotech Poised for a Quick Double-Digit Pop
Small-Cap Biotech Poised for a Quick Double-Digit Pop
Yahoo/Street Authority
Insmed
Arikace
cystic fibrosis
Flag link:
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
Seeking Alpha
BioDelivery Sciences
Acadia
Amarin
Keryx
Insmed
opiod addiction
Flag link:
Quickly Approaching Biopharma Catalyst Events
Quickly Approaching Biopharma Catalyst Events
Seeking Alpha
Agenus
Aveo Pharmaceuticals
Insmed
GSK
Sarepta
Flag link:
Orphan Status for Insmed's Arikace
Orphan Status for Insmed's Arikace
Yahoo/Zacks
Arikace
orphan drugs
Insmed
non-tuberculous mycobacteria
Flag link:
Insmed Earnings: An Early Look
Insmed Earnings: An Early Look
Motley Fool
Insmed
earnings
Flag link:

Pages